CME Group Inc., US12572Q1058

CME Group stock rises to EUR 249.30 at USD 100.4 billion value

Published on 10/09/2026 at 19:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CME Group stock costs EUR 249.30 on October 9, 2026, up 1.29 percent. Its market value is USD 100.4 billion and P/E is 23.67.

Key points in brief

  • CME Group stock was EUR 249.30 at Lang & Schwarz on October 9, 2026 at 7:10 p.m. CEST, up 1.29 percent.
  • Market capitalization was USD 100.4 billion and the P/E ratio was 23.67.
  • Morgan Stanley raised its target to USD 337 from USD 330 while maintaining an Overweight rating on October 9, 2026.
  • CME Group is scheduled to report third-quarter 2026 results on October 21, 2026.
Draufsicht-Arrangement mit Aktienzertifikat, ISIN-Karte, Goldstift und Futures-Dokumenten
CME Group Inc. Flatlay mit Aktienzertifikat und ISIN-Karte, US12572Q1058 inmitten von Finanzinstrumenten arrangiert, Illustration mit AI erstellt.

CME Group Inc. (ISIN US12572Q1058) was trading at EUR 249.30 at Lang & Schwarz on October 9, 2026 at 7:10 p.m. CEST, up 1.29 percent versus the EUR 246.13 prior close. Its market capitalization was USD 100.4 billion, giving the stock a substantial valuation base even as the euro quote remained separate from the Nasdaq price.

Price holds above the prior close

The Lang & Schwarz quote places CME Group stock in after-hours trading from a German investor perspective. The reference price rose by EUR 3.17 during the session, while the bid was EUR 249.05 and the ask EUR 249.55.

On Nasdaq, CME Group was last at USD 279.12 on October 9, 2026 at 1:13 p.m. ET, up 0.97 percent from USD 276.44. The same quote showed a 52-week range of USD 218.31 to USD 329.16, keeping the US listing below its yearly high while the euro price remained the report's primary market figure.

Valuation and analyst target

GuruFocus reported on October 9, 2026 that Morgan Stanley maintained an Overweight rating and raised its price target to USD 337 from USD 330. The new target was 20.74 percent above the Nasdaq price of USD 279.12, while CME Group's trailing P/E ratio was 23.67.

MarketBeat lists October 21, 2026 as CME Group's next reporting date before the market opens. For the second quarter of 2026, the company reported USD 1.71 billion in revenue and earnings per share of USD 2.99, compared with USD 1.68 billion and USD 2.91 expected by analysts, respectively, according to MarketBeat.

Comparison with peers

CME Group Inc. (NASDAQ, USD): plus 1.29 percent, P/E 23.67, market capitalization USD 100.4 billion
Intercontinental Exchange (NYSE, USD): plus 0.81 percent, P/E 22.14, market capitalization USD 87.9 billion
Cboe Global Markets (Cboe, USD): plus 3.32 percent, P/E 23.64, market capitalization USD 31.8 billion

Trading reference for Germany

CME Group stock was trading at EUR 249.30 at Lang & Schwarz on October 9, 2026 at 7:10 p.m. CEST, up 1.29 percent versus the Lang & Schwarz prior close of EUR 246.13. The quote was in the after-hours phase under the Xetra session model.

The further course of trading is shown by the continuously updated real-time quote of CME Group stock.

CME Group stock at a glance

  • Company: CME Group Inc.
  • ISIN: US12572Q1058
  • Ticker: CME
  • Primary exchange: NASDAQ
  • Price Lang & Schwarz (as of October 9, 2026, 7:10 p.m. CEST): EUR 249.30
  • Change versus prior close: plus 1.29 percent
  • Prior close Lang & Schwarz (October 8, 2026): EUR 246.13
  • Market capitalization: USD 100.4 billion (as of October 9, 2026)
  • 52-week range: USD 218.31-329.16 (as of October 9, 2026)
  • Sector / Industry: Financial Services / Financial - Data and Stock Exchanges
  • Next earnings date: October 21, 2026

Market context: Market report S&P 500.

More news and analyses on CME Group stock

Disclaimer...

en | US12572Q1058 | CME GROUP INC. | boerse | 70282306 | bgmi